Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | CXCL12 |
| Upstream (Parents) |
|---|
| (<<) SRPX → CXCL12 |
| (<<) AKAP12 → CXCL12 |
| (<<) LHFP → CXCL12 |
| (<<) DCN → CXCL12 |
| (<<) PTGER4 → CXCL12 |
| Downstream (Children) |
|---|
| CXCL12 → SRPX (>>) |
| CXCL12 → AKAP12 (>>) |
| CXCL12 → KIT (>>) |
| CXCL12 → ETV2 (>>) |
| CXCL12 → ACSL4 (>>) |
| CXCL12 → HEG1 (>>) |
| CXCL12 → LHFP (>>) |
| CXCL12 → SLC31A2 (>>) |
| CXCL12 → CSGALNACT1 (>>) |
| CXCL12 → BHLHE41 (>>) |
| CXCL12 → IRAK3 (>>) |
| CXCL12 → FAM70A (>>) |
| CXCL12 → AKT3 (>>) |
| CXCL12 → SGCE (>>) |
| CXCL12 → ALDH1A3 (>>) |
| CXCL12 → SCNN1B (>>) |
| CXCL12 → F13A1 (>>) |
| CXCL12 → DPYSL2 (>>) |
| CXCL12 → FZD7 (>>) |
| CXCL12 → PTGER4 (>>) |
